Vanda Pharmaceuticals (VNDA) Stock Chart & Stock Price History $4.36 -0.07 (-1.58%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$4.38 +0.01 (+0.34%) As of 08/15/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vanda Pharmaceuticals Stock Price Performance The Vanda Pharmaceuticals (VNDA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 16.15%, with a year-to-date return of -8.98%. In the past month, the stock has decreased 9.36%, reflecting recent market activity. As of the latest close, Vanda Pharmaceuticals traded at $4.36 with a market cap of $257.63 million and volume of 942,342 shares. Five years ago, the stock traded at $11.67, representing a 62.64% decrease over that period. At the time, it had a market cap of $656.89 million and a volume of 331,566 shares. Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.06%1 Month Performance-9.36%3 Month Performance+4.81%Year-To-Date Performance-8.98%1 Year Performance-16.15%5 Year Performance-62.64% VNDA Stock Chart for Saturday, August, 16, 2025 VNDA Chart by TradingView Vanda Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$4.43$4.36-1.58%$4.46$4.36942,342 shs$257.63 million08/14/2025$4.36$4.43+1.61%$4.47$4.30342,375 shs$261.76 million08/13/2025$4.31$4.36+1.16%$4.45$4.31486,419 shs$257.63 million08/12/2025$4.19$4.31+2.86%$4.37$4.17569,639 shs$254.68 million08/11/2025$4.20$4.19-0.24%$4.28$4.15457,925 shs$247.58 million08/08/2025$4.20$4.20$4.23$4.16304,475 shs$248.17 million08/07/2025$4.22$4.20-0.47%$4.22$4.14310,692 shs$248.18 million08/06/2025$4.21$4.22+0.24%$4.26$4.15485,040 shs$249.36 million08/05/2025$4.26$4.21-1.17%$4.28$4.17365,777 shs$248.11 million08/04/2025$4.19$4.26+1.67%$4.28$4.15598,638 shs$251.72 million Get the Latest News and Ratings for VNDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$4.26$4.19-1.64%$4.27$4.16766,997 shs$246.92 million07/31/2025$4.67$4.26-8.78%$4.43$4.181.43 million shs$251.04 million07/30/2025$4.68$4.67-0.21%$4.89$4.651.05 million shs$275.22 million07/29/2025$4.70$4.68-0.43%$4.79$4.66351,178 shs$275.79 million07/28/2025$4.74$4.70-0.84%$4.85$4.70299,039 shs$276.97 million07/25/2025$4.79$4.74-1.04%$4.84$4.71401,037 shs$279.33 million07/24/2025$4.84$4.79-1.03%$4.95$4.79390,302 shs$282.29 million07/23/2025$4.71$4.84+2.76%$4.85$4.68464,832 shs$285.22 million07/22/2025$4.66$4.71+1.07%$4.74$4.60337,740 shs$277.56 million07/21/2025$4.78$4.66-2.51%$4.83$4.65461,920 shs$274.61 million07/18/2025$4.86$4.78-1.65%$4.92$4.77295,823 shs$281.69 million07/17/2025$4.81$4.86+1.04%$4.89$4.76326,615 shs$286.42 million07/16/2025$4.76$4.81+1.05%$4.88$4.74695,197 shs$283.45 million07/15/2025$4.97$4.76-4.23%$4.98$4.73454,540 shs$280.53 million Related Companies OPKO Health Stock Chart Geron Stock Chart Zenas BioPharma Stock Chart Myriad Genetics Stock Chart Rigel Pharmaceuticals Stock Chart Emergent Biosolutions Stock Chart Verastem Stock Chart Lexicon Pharmaceuticals Stock Chart XOMA Royalty Stock Chart Crescent Biopharma Stock Chart Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VNDA) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersAmerica’s Finest Hour: Sept 30After This White House Deadline, All Bets Are Off The White House just issued a sweeping order that could s...Stansberry Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access